Page 7 of 9
Organic & Biomolecular Chemistry
1300, 1289, 1139, 1078, 814, 699, 659 cm-1. 1H NMR (300 MHz,
DMSO-d6, ): 7.87 (br t, 1H, JNH,H = 6.2, NH), 7.75-7.69 (m, 2H, 60 stirred at rt for 1 h. Then, saturated NaHCO3(aq) was added, and
monohydrate (20 mg, 0.105 mmol) were added. The mixture was
DOI: 10.1039/C3OB41160E
H-Ts), 7.44-7.39 (m, 2H, H-Ts), 7.36-7.19 (m, 5H, H-Ar), 6.04
(dt, 1H, J = 6.1, J = 1.9, H-3 or H-4), 5.94 (ddd, 1H, J = 6.1, J =
2.4, J = 1.4, H-3 or H-4), 5.20-5.10 (m, 2H, H-5, H-2), 4.27 (d,
2H, CH2Ph), 3.65 (dd, 1H, JH,H = 14.3, JH,5 = 4.5, CHHTs), 3.58
the crude was extracted with DCM, dried over Na2SO4,
concentrated under reduced pressure, and purified by column
chromatography on silica gel (EtOAc/cyclohexane, 1:6) to give
16 (272 mg, 72%) as an amorphous yellow solid. IR: 2973, 2933,
5
(dd, 1H, JH,5 = 7.4, CHHTs), 2.36 (s, 3H, CH3 of Ts). 13C NMR 65 1711, 1595, 1573, 1370, 1321, 1295, 1147, 1115, 1097, 1075,
1
(75.4 MHz, DMSO-d6, ): 169.6 (CO), 144.5, 138.9, 136.7, 129.8
(C-Ar), 129.1 (C-3 or C-4), 128.3 (C-Ar), 128.0 (C-3 or C-4),
10 127.3, 127.1, 126.9 (C-Ar), 85.9, 81.2 (C-2, C-5), 60.3 (CH2Ts),
41.7 (CH2Ph), 21.0 (CH3 of Ts). MS(CI) m/z: 372 (40%,
665 cm-1. H NMR (300 MHz, CDCl3, ): 7.87-7.82 (m, 2H, H-
Ts), 7.38 (d, 2H, J = 8.1, H-Ts), 4.77 (br s, 1H, H-1 or H-4), 4.66
(br s, 1H, H-1 or H-4), 4.56 (d, 1H, J = 5.5, H-5 or H-6), 4.44 (d,
1H, J = 5.5, H-5 or H-6), 2.46 (s, 3H, CH3 of Ts), 1.44 (s, 3H,
[M+H)]+). HRMS(CI) m/z: [M+H]+ Calcd for C20H22NO4S 70 C(CH3)2), 1.31 (s, 3H, C(CH3)2), 1.27 (s, 9H, C(CH3)3). 13C NMR
372.1270; Found 372.1279.
(125 MHz, CDCl3, ): 154.4 (CO of Boc), 145.8 (C-Ar), 144.6
(br, C-2 or C-3), 136.6 (C-Ar), 136.2 (br, C-2 or C-3), 130.3,
128.1 (C-Ar), 117.0 (C(CH3)2), 81.5 (C(CH3)3), 80.4, 78.8 (C-5,
C-6), 72.7, 66.8 (C-1, C-4), 28.0 (C(CH3)3), 26.3, 25.7 (C(CH3)2),
(±)-(4SR)-Methyl 4-(p-toluenesulfonylmethyl)cyclohex-1-
15 enecarboxylate (7a). To a solution of compound 7 (29.7 mg,
0.107 mmol) in anhydrous MeOH/THF (3:1, 1.3 mL), a solution
of NaOMe/MeOH (0.2 equiv.) was added and the mixture was 75 21.8 (CH3 of Ts). MS(LSI) m/z: 524 (36%, [M+Na]+), 522 (33%,
stirred for 48 h at 60 ºC. Then, acidic resin IR-120 H+ was added
till pH 7, the resin was filtered and the solution evaporated to
20 give pure 7a (33 mg, quant.) as a colourless oil. IR: 2923, 1708,
1650, 1596, 1435, 1299, 1287, 1251, 1144, 1084, 815, 664 cm-1.
[M+Na]+), 402 (25%, [M+H-isobutene-CO2]+), 400 (23%, [M+H-
isobutene-CO2]+). HRMS(LSI) m/z: [M+Na]+ Calcd for
C21H26NO6S79BrNa 522.0562; found 522.0565.
(±)-2-Bromo-5,6-exo-isopropylidenedioxy-3-(p-toluene-
1H NMR (300 MHz, CDCl3, ): 7.79-7.75 (m, 2H, H-Ts), 7.37- 80 sulfonyl)-7-oxabicyclo[2.2.1]hept-5-ene (17). This compound
7.32 (m, 2H, H-Ts), 6.86 (m, 1H, H-2), 3.70 (s, 3 H, COOCH3),
was prepared as described for 16, except that pure 14 (115 mg,
0.351 mmol) was used as starting material. Crude 17 was purified
by column chromatography on silica gel (EtOAc/cyclohexane,
1:6) to give 17 (77 mg, 55%) as a colourless oil. IR: 2928, 1583,
3.07 (dd, 1H, JH,H = 14.1, JH,4 = 5.9, CHHTs), 3.00 (dd, 1H, JH,4
=
25 6.9, CHHTs), 2.59-1.85 (m, 6H, CH2, H-4), 2.44 (s, 3H, CH3 of
Ts), 1.42 (m, 1H, CH2). 13C NMR (75.4 MHz, CDCl3, ): 167.5
(COOCH3), 144.9 (C-Ar), 137.4 (C-2), 137.1, 130.1, 127.9 (C- 85 1454, 1374, 1326, 1208, 1152, 1072, 856, 809, 663 cm-1. 1H
Ar, C-1), 61.6 (CH2Ts), 51.7 (COOCH3), 31.7, 28.2, 28.1 23.3 (3
CH2, C-4), 21.7 (CH3 of Ts). MS(CI) m/z: 309 (21%, [M+H]+).
30 HRMS(CI) m/z: [M+H]+ Calcd for C16H21O4S 309.1161; Found
309.1157.
NMR (300 MHz, CDCl3, ): 7.86-7.79 (m, 2H, H-Ts), 7.38 (d,
2H, J = 8.0, H-Ts), 4.86 (d, 1H, J = 1.2, H-1 or H-4), 4.71 (d,
1H, J = 1.2, H-1 or H-4), 4.59 (d, 1H, J = 5.3, H-5 or H-6), 4.52
(d, 1H, J = 5.3, H-5 or H-6), 2.46 (s, 3H, CH3 of Ts), 1.45 (s, 3H,
(±)-(9SR,10SR)-Methyl 10-(p-toluenesulfonylmethyl)-9,10- 90 C(CH3)2), 1.32 (s, 3H, C(CH3)2). 13C NMR (75.4 MHz, CDCl3,
dihydroanthracene-9-carboxylate (8a). To
a
solution of
): 145.9, 144.4, 136.4, 134.7 (C-Ar, C-2, C-3), 130.4, 128.1 (C-
Ar), 117.0 (C(CH3)2), 89.3, 83.9 (C-1, C-4), 80.2, 78.9 (C-5, C-
6), 26.2, 25.9 (C(CH3)2), 21.9 (CH3 of Ts). MS(LSI) m/z: 403
(3%, [M+H]+), 401 (4%, [M+H]+), 387 (10%, [M-Me]+), 385
compound 8 (20 mg, 0.053 mmol) in anhydrous MeOH/CH2Cl2
35 (1:1.5, 1 mL), NaOMe (1.2 mg, 0.022 mmol) was added and the
mixture was stirred at rt for 20 h. Then the solution was
evaporated to give pure 8a (22 mg, quant.) as a yellowish oil. IR: 95 (10%, [M-Me]+). HRMS(LSI) m/z: [M+Na]+ Calcd for
2951, 2924, 1730, 1596, 1485, 1450, 1432, 1402, 1287, 1146,
C16H17O5S79BrNa (M+Na): 422.9878; Found 422.9879.
(±)-2-Bromo-5,6-exo-isopropylidenedioxy-3-(p-toluene-
1
1135, 758, 736, 672 cm-1. H NMR (300 MHz, CDCl3, ): 7.79-
40 7.76 (m, 2H, H-Ar), 7.52-7.49 (m, 2H, H-Ar), 7.37-7-22 (m, 8H,
sulfonyl)bicyclo[2.2.1]hept-2-ene (18). This compound was
prepared as described for 16, except that pure 15 (406 mg, 1.25
100 mmol) was used as starting material. Crude 18 was purified by
column chromatography on silica gel (EtOAc/cyclohexane, 1:5)
to give 18 (351 mg, 70%) as a colourless oil. IR: 2990, 2935,
1595, 1568, 1449, 1375, 1322, 1265, 1207, 1149, 1067, 1051,
H-Ar), 4.99 (s, 1H, H-9), 4.91 (t, 1H, J = 5.6, H-10), 3.64 (d,
2H, CH2Ts), 3.62 (s, 3 H, COOCH3), 2.42 (s, 3H, CH3 of Ts). 13
C
NMR (75.4 MHz, CDCl3, ): 172.9 (COOCH3), 144.6, 137.9,
137.4, 133.3, 129.9, 129.4, 128.9, 128.3, 128.0, 127.4 (C-Ar),
45 65.2 (CH2Ts), 52.8 (COOCH3), 51.8 (C-9), 39.5 (C-10), 21.7
(CH3 of Ts). MS(LSI) m/z: 429 (18%, [M+Na]+). HRMS(LSI)
1
853, 813, 673, 652 cm-1. H NMR (300 MHz, CDCl3, ): 7.85-
m/z: [M+Na]+ Calcd for C24H22O4SNa 429.1137; Found 105 7.79 (m, 2H, H-Ts), 7.38-7.33 (m, 2H, H-Ts), 4.34 (m, 1H, H-5
429.1149.
(±)-7-tert-Butoxycarbonyl-2-bromo-5,6-exo-isopropylidene-
50 dioxy-3-(p-toluenesulfonyl)-7-azabicyclo[2.2.1]hept-2-ene (16).
To a solution of 13 (321 mg, 0.75 mmol) in acetone/H2O (9:1, 21
or H-6), 4.31 (m, 1H, H-5 or H-6), 3.14 (m, 1H, H-1 or H-4), 3.00
(m, 1H, H-1 or H-4), 2.45 (s, 3H, CH3 of Ts), 2.00 (dt, 1H, J7a,7b
= 9.7, J = 1.5, H-7a), 1.91 (dq, 1H, J = 1.6, H-7b), 1.43 (s, 3H,
C(CH3)2), 1.30 (s, 3H, C(CH3)2). 13C NMR (75.4 MHz, CDCl3,
mL) were added NMO (154 mg, 1.31 mmol) and a solution of 110 ): 145.3, 144.7, 137.1, 135.9 (C-Ar, C-2, C-3), 130.2, 128.0 (C-
t
OsO4 in BuOH (2.5 wt %, 0.69 mL). After stirring for 1 h, the
reaction mixture was cooled at 0 ºC and saturated NaHSO3(aq)
55 was slowly added. Then, the crude was extracted with EtOAc,
dried over Na2SO4 and concentrated under reduced pressure. The
Ar), 115.0 (C(CH3)2), 80.4, 79.6 (C-5, C-6), 58.2, 49.4 (C-1, C-
4), 42.4 (C-7), 25.9, 24.6 (C(CH3)2), 21.8 (CH3 of Ts). MS(CI)
m/z: 401 (15%, [M+H]+), 399 (15%, [M+H]+). HRMS(CI) m/z:
[M+H]+ Calcd. for C17H20O4S79Br 399.0266; Found 399.0265.
resulting residue was dissolved in acetone (9 mL) and 2,2- 115 (±)-3-endo
and
3-exo-7-tert-Butoxycarbonyl-5,6-exo-
dimethoxypropane (DMP) (0.63 mL, 5.14 mmol) and PTSA
isopropylidenedioxy-3-(p-toluenesulfonyl)-7-azabicyclo-
This journal is © The Royal Society of Chemistry [year]
Journal Name, [year], [vol], 00–00 |
7